Breaking News
Get 45% Off 0
🤖 Are you in? These 5 AI-picked stocks are up 15%+
Read article

Stock Markets Analysis & Opinion

Contribute
Zacks Investment Research
On Falling Knives And Forward Perspectives By Zacks Investment Research - Feb 05, 2018

Tuesday, February 6, 2018…Aaand the numbers just keep plummeting. This has been a period of “falling knives,” and plenty of investors who’d grown used to strong, steady gains...

Zacks Investment Research
DaVita (DVA) To Report Q4 Earnings: What's In The Cards? By Zacks Investment Research - Feb 05, 2018

DaVita HealthCare Partners Inc. (NYSE:DVA) is scheduled to report fourth-quarter 2017 results on Feb 13, after the market closes.In the third quarter, the company reported adjusted earnings of 81...

Zacks Investment Research
Can Evergreen Titles Drive Glu Mobile's (GLUU) Q4 Earnings? By Zacks Investment Research - Feb 05, 2018

Glu Mobile Inc. (NASDAQ:GLUU) is slated to release fourth-quarter 2017 results on Feb 8.Last quarter, the company posted a negative earnings surprise of 200.00%. Moreover, it has delivered an...

Zacks Investment Research
BP Plc (BP) Q4 Earnings Miss Estimates, Skyrocket Y/Y By Zacks Investment Research - Feb 05, 2018

BP plc (LON:BP) (NYSE:BP) reported a year-over-year rise in fourth-quarter 2017 earnings, courtesy of record oil and gas production and higher commodity price realizations. Increased refinery...

Zacks Investment Research
Gartner (IT) Misses On Q4 Earnings Despite Higher Revenues By Zacks Investment Research - Feb 05, 2018

Information technology services provider Gartner, Inc. (NYSE:IT) reported relatively healthy fourth-quarter 2017 results with year-over-year growth in revenues and total contract value. Adjusted...

Zacks Investment Research
Pfizer Files For Xtandi In Early Stage Prostate Cancer By Zacks Investment Research - Feb 05, 2018

Pfizer Inc. (NYSE:PFE) and its Japanese partnerAstellas Pharma Inc. announced detailed results from a late-stage study which can expand the label of its prostate cancer drug Xtandi to include...

Zacks Investment Research
What To Expect From VeriSign (VRSN) This Earnings Season? By Zacks Investment Research - Feb 05, 2018

VeriSign Inc. (NASDAQ:VRSN) is scheduled to report fourth-quarter 2017 results on Feb 8.We note that the company has surpassed the Zacks Consensus Estimate in each of the trailing four quarters,...

Zacks Investment Research
Phibro Animal (PAHC) Beats On Q2 Earnings, Raises Guidance By Zacks Investment Research - Feb 05, 2018

Phibro Animal Health Corporation (NASDAQ:PAHC) reported adjusted earnings per share (EPS) of 44 cents in the second quarter of fiscal 2018, up 12.8% year over year. Adjusted EPS surpassed the Zacks...

Zacks Investment Research
Industrial Stock Earnings Roster For Feb 7: BLL, CCK & BERY By Zacks Investment Research - Feb 05, 2018

We are in the thick of the fourth-quarter earnings season with 251 index members having released their quarterly numbers. The picture so far is encouraging with the companies coming up with 16%...

Zacks Investment Research
Macerich (MAC) Q4 FFO Misses Estimates, Revenues Fall Y/Y By Zacks Investment Research - Feb 05, 2018

Retail REIT The Macerich Company (NYSE:MAC) delivered fourth-quarter 2017 adjusted funds from operations (FFO) per share of $1.13, missing the Zacks Consensus Estimate by a cent. Results reflect...

Zacks Investment Research
Lennox (LII) Beats On Q4 Earnings, Misses Revenue Estimate By Zacks Investment Research - Feb 05, 2018

Lennox International, Inc. (NYSE:LII) offers premium and innovative climate control products in the global ventilation, heating, refrigeration and air conditioning markets. Residential Heating &...

Zacks Investment Research
HAS Vs. TTWO: Which Stock Is Poised For Better Q4 Earnings? By Zacks Investment Research - Feb 05, 2018

We are in the thick of the Q4 earnings season with 251 of the S&P 500 members having released their quarterly numbers (as of Feb 2) and another 92 scheduled to report.Per the latest Earnings...

Zacks Investment Research
TransDigm's (TDG) Q1 Earnings Impressive, Revenues Beat By Zacks Investment Research - Feb 05, 2018

TransDigm Group Incorporated (NYSE:TDG) reported first-quarter fiscal 2018 adjusted earnings of $5.58 per share, which reflected growth of a whopping 121.4% year over year. The bottom line gained...

Zacks Investment Research
Will Lower Ad Revenues Hurt Twitter's (TWTR) Q4 Earnings? By Zacks Investment Research - Feb 05, 2018

Twitter (NYSE:TWTR) is set to report fourth-quarter 2017 results on Feb 8. The company beat the Zack Consensus Estimate in all the trailing four quarters, delivering an average positive surprise of...

Zacks Investment Research
Negative Duration Bond ETF (AGND) Hits New 52-Week High By Zacks Investment Research - Feb 05, 2018

For investors seeking momentum, WisdomTree Barclays (LON:BARC) U.S. Aggregate Bond Negative Duration Fund AGND is probably on radar now. The fund just hit a 52-week high, and is up 4.2% from its...

Continue with Apple
Continue with Google
or
Sign up with Email